Biofrontera (BFRI) Income from Continuing Operations (2020 - 2025)
Biofrontera has reported Income from Continuing Operations over the past 6 years, most recently at 5640000.0 for Q4 2025.
- For Q4 2025, Income from Continuing Operations rose 504.01% year-over-year to 5640000.0; the TTM value through Dec 2025 reached 10536000.0, up 40.67%, while the annual FY2025 figure was 10536000.0, 40.67% up from the prior year.
- Income from Continuing Operations for Q4 2025 was 5640000.0 at Biofrontera, up from 6649000.0 in the prior quarter.
- Over five years, Income from Continuing Operations peaked at 5640000.0 in Q4 2025 and troughed at 16012000.0 in Q3 2021.
- A 5-year average of 4338900.0 and a median of 3932000.0 in 2021 define the central range for Income from Continuing Operations.
- Biggest five-year swings in Income from Continuing Operations: crashed 7698.39% in 2021 and later skyrocketed 504.01% in 2025.
- Year by year, Income from Continuing Operations stood at 14505000.0 in 2021, then surged by 80.8% to 2785000.0 in 2022, then soared by 226.61% to 3526000.0 in 2023, then tumbled by 139.59% to 1396000.0 in 2024, then skyrocketed by 504.01% to 5640000.0 in 2025.
- Business Quant data shows Income from Continuing Operations for BFRI at 5640000.0 in Q4 2025, 6649000.0 in Q3 2025, and 5324000.0 in Q2 2025.